\
&
Contact us
\
&
Contact us
Published on | 6 years ago
ProgrammesExtended submission date: ERC-2020-COG
This morning of 4th February 2020, the European Commission experienced extensive issues with the EU Login and hence applicants were blocked from submitting their proposals to the ERC Consolidator Grant 2020.
The ERC has therefore decided to extend the deadline of the ERC Consolidator Grant 2020 call by 24 hours.
The new deadline in the submission system will be tomorrow 5th February at 17:00 (Brussels time).
Source: Funding updates
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The Digital Europe project LDT4SSC (Local Digital Twins for Smart and Sustainable Communities) has launched an Open Call for Pilots to engage European local and regional authorities, as well as a wide range of stakeholders, including public administrations at local, regional, and national levels, businesses, technology developers, suppliers, r... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
